CD (Suzhou) Biopharma Co., Ltd.
1 clinical trials · Sponsor
◉ Watch CD (Suzhou) Biopharma Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CD-001 in Patients With Advanced Solid Tumors (NCT06801470) | CD (Suzhou) Biopharma Co., Ltd. | 2025-01-08 |
Track CD (Suzhou) Biopharma Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.